Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1086619 London, X0
Back to ARQT Full portfolio

Position in ARQT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,736,213
+$277,587 QoQ
Shares Held
104,356
0.0% QoQ
Ownership
0.083%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#98
of 271 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARQT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $692,439,062 across 60 Biotechnology names. ARQT ranks #42 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 1,410,943 $99,683,122
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 169,270 $84,081,485
3 EXEL
Exelixis, Inc.
 669,005 $36,400,560
4 INSM
INSMED Inc
 298,372 $31,812,422
5 ALNY
Alnylam Pharmaceuticals, Inc.
 95,194 $28,656,248
6 MDGL
Madrigal Pharmaceuticals, Inc.
 51,630 $27,722,728
7 VERA
Vera Therapeutics, Inc.
 510,787 $21,917,869
8 TVTX
Travere Therapeutics, Inc.
 379,611 $21,565,700

All Filings in ARQT

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,736,213 104,356
2026-03-31 $2,458,626 104,356
2025-12-31 $1,659,228 57,136
2025-09-30 $1,065,816 56,542
2024-06-30 $2,061,782 221,697
2024-03-31 $179,717 18,135
2023-12-31 $36,815 11,398
2023-09-30 $60,523 11,398